North America Brain Implants Market

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030

Analysis - by Treatment [Deep Brain Stimulation, Spinal Cord Stimulation, Vagus Nerve Stimulator, Invasive and Non-Invasive Brain-Computer Interface, Responsive Neurostimulation for Seizures, Auditory Brainstem Implant (Retrocochlear Hearing Impairment and Cochlear Hearing Impairment), and Ophthalmic Aid/Implant], Application [Chronic Pain, Parkinson\'s Disease, Alzheimer\'s Disease, Epilepsy, Essential Tremor, Depression, Dystonia, Amyotrophic Lateral Sclerosis (ALS), and Neurofibromatosis 2], and End User (Hospitals and Specialized Clinics/Neurological Centers)

No. of Pages: 108
Report Code: BMIRE00029805
Category: Life Sciences
North America Brain Implants Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. North America Brain Implants Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. North America Brain Implants Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. North America Brain Implants Market Regional Analysis

6.2 North America Brain Implants Market Revenue 2020-2030 (US$ Million)
6.3 North America Brain Implants Market Forecast Analysis

7. North America Brain Implants Market Analysis – by Treatment

7.1 Deep Brain Stimulation
  • 7.1.1 Overview
  • 7.1.2 Deep Brain Stimulation: North America Brain Implants Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Spinal Cord Stimulation
  • 7.2.1 Overview
  • 7.2.2 Spinal Cord Stimulation: North America Brain Implants Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.3 Vagus Nerve Stimulator
  • 7.3.1 Overview
  • 7.3.2 Vagus Nerve Stimulator: North America Brain Implants Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.4 Invasive and Non-Invasive Brain-Computer Interface
  • 7.4.1 Overview
  • 7.4.2 Invasive and Non-Invasive Brain-Computer Interface: North America Brain Implants Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.5 Responsive Neurostimulation for Seizures
  • 7.5.1 Overview
  • 7.5.2 Responsive Neurostimulation for Seizures: North America Brain Implants Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.6 Auditory Brainstem Implant
  • 7.6.1 Overview
  • 7.6.2 Auditory Brainstem Implant: North America Brain Implants Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.7 Ophthalmic Aid/Implant
  • 7.7.1 Overview
  • 7.7.2 Ophthalmic Aid/Implant: North America Brain Implants Market – Revenue and Forecast, 2020-2030 (US$ Million)

8. North America Brain Implants Market Analysis – by Application

8.1 Chronic Pain
  • 8.1.1 Overview
  • 8.1.2 Chronic Pain: North America Brain Implants Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 Parkinson\'s Disease
  • 8.2.1 Overview
  • 8.2.2 Parkinson\'s Disease: North America Brain Implants Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.3 Alzheimer\'s Disease
  • 8.3.1 Overview
  • 8.3.2 Alzheimer\'s Disease: North America Brain Implants Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.4 Epilepsy
  • 8.4.1 Overview
  • 8.4.2 Epilepsy: North America Brain Implants Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.5 Essential Tremor
  • 8.5.1 Overview
  • 8.5.2 Essential Tremor: North America Brain Implants Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.6 Depression
  • 8.6.1 Overview
  • 8.6.2 Depression: North America Brain Implants Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.7 Dystonia
  • 8.7.1 Overview
  • 8.7.2 Dystonia: North America Brain Implants Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.8 Amyotrophic Lateral Sclerosis
  • 8.8.1 Overview
  • 8.8.2 Amyotrophic Lateral Sclerosis: North America Brain Implants Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.9 Neurofibromatosis 2
  • 8.9.1 Overview
  • 8.9.2 Neurofibromatosis 2: North America Brain Implants Market – Revenue and Forecast, 2020-2030 (US$ Million)

9. North America Brain Implants Market Analysis – by End User

9.1 Hospitals and Specialized Clinics/Neurological Centers
  • 9.1.1 Overview
  • 9.1.2 Hospitals and Specialized Clinics/Neurological Centers : North America Brain Implants Market – Revenue and Forecast, 2020-2030 (US$ Million)

10. North America Brain Implants Market – North America Analysis

10.1 Overview

10.2 North America
  • 10.2.1 North America Brain Implants Market Breakdown, by Key Country, 2023 and 2030 (%)
  • 10.2.1.1 North America Brain Implants Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 US: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.2.1.1.1 US: North America Brain Implants Market Breakdown, by Treatment
    • 10.2.1.1.2 US: North America Brain Implants Market Breakdown, by Application
    • 10.2.1.1.3 US: North America Brain Implants Market Breakdown, by End User
  • 10.2.1.2 Canada: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.2.1.2.1 Canada: North America Brain Implants Market Breakdown, by Treatment
    • 10.2.1.2.2 Canada: North America Brain Implants Market Breakdown, by Application
    • 10.2.1.2.3 Canada: North America Brain Implants Market Breakdown, by End User
  • 10.2.1.3 Mexico : North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.2.1.3.1 Mexico : North America Brain Implants Market Breakdown, by Treatment
    • 10.2.1.3.2 Mexico : North America Brain Implants Market Breakdown, by Application
    • 10.2.1.3.3 Mexico : North America Brain Implants Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1 Abbott Laboratories
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Blackrock Microsystems Inc
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Boston Scientific Corp
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 BrainGate
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Fisher Wallace Laboratories Inc
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Functional Neuromodulation Ltd
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Medtronic Plc
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Neuralink Corp
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 NeuroPace Inc
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 NeuroSky Inc
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments
13.11 Neurospine LLC
  • 13.11.1 Key Facts
  • 13.11.2 Business Description
  • 13.11.3 Products and Services
  • 13.11.4 Financial Overview
  • 13.11.5 SWOT Analysis
  • 13.11.6 Key Developments
13.12 ONWARD Medical NV
  • 13.12.1 Key Facts
  • 13.12.2 Business Description
  • 13.12.3 Products and Services
  • 13.12.4 Financial Overview
  • 13.12.5 SWOT Analysis
  • 13.12.6 Key Developments
13.13 Paradromics Inc
  • 13.13.1 Key Facts
  • 13.13.2 Business Description
  • 13.13.3 Products and Services
  • 13.13.4 Financial Overview
  • 13.13.5 SWOT Analysis
  • 13.13.6 Key Developments
13.14 Renishaw Plc
  • 13.14.1 Key Facts
  • 13.14.2 Business Description
  • 13.14.3 Products and Services
  • 13.14.4 Financial Overview
  • 13.14.5 SWOT Analysis
  • 13.14.6 Key Developments
13.15 Synchron Inc
  • 13.15.1 Key Facts
  • 13.15.2 Business Description
  • 13.15.3 Products and Services
  • 13.15.4 Financial Overview
  • 13.15.5 SWOT Analysis
  • 13.15.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

The List of Companies - North America Brain Implants Market

  • Abbott Laboratories
  • Blackrock Microsystems Inc
  • Boston Scientific Corp
  • BrainGate
  • Fisher Wallace Laboratories Inc
  • Functional Neuromodulation Ltd
  • Medtronic Plc
  • Neuralink Corp
  • NeuroPace Inc
  • NeuroSky Inc
  • Neurospine LLC
  • ONWARD Medical NV
  • Paradromics Inc
  • Renishaw Plc
  • Synchron Inc
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)